Maynard Um
-
-
-
-
-
-
-
TD Cowen Defending Dianthus Therapeutics (DNTH): 'We see weakness as a buying opportunity'
-
-
-
-
-
-
-
Sanofi (SNY) Tops Q1 EPS by 9c
-
-
-
-
-
-
-
Sanofi cut to "neutral" at BofA on CEO change, shares drop over 6%
-
-
-
-
-
-
-
FDA delays reviews of Sanofi's Tzield and Disc Medicine's bitopertin
-
-
-
-
-
-
-
TD Cowen Reiterates Hold Rating on Sanofi (SAN:FP) (SNY)
-
-
-
-
-
-
-
At Least 7 Drug Companies to Announce Price Cuts with Trump at White House - WaPo
-
-
-
-
-
-
-
Sanofi (SNY) Tops Q3 EPS by 72c
-
420,450 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

